Curated News
By: NewsRamp Editorial Staff
March 30, 2026
SS Innovations Expands Robotic Surgery Access to Four New Countries
TLDR
- SS Innovations gains competitive edge with regulatory approvals in Colombia, Oman, Sri Lanka, and Kenya for its cost-effective SSi Mantra surgical robotic system.
- The SSi Mantra system received approvals from INVIMA, DGPA&DC, NMRA, and PPB in late 2025 and early 2026, expanding its presence to eleven countries.
- SS Innovations' affordable robotic surgery technology democratizes access to advanced medical care in underserved regions, improving global healthcare equity.
- The SSi Mantra has performed over 150 telesurgeries and completed 7,885 cumulative surgeries, including 390 cardiac and 121 pediatric procedures.
Impact - Why it Matters
This development matters because it addresses critical gaps in global healthcare by making advanced surgical robotics more accessible and affordable in underserved regions. Robotic surgery offers precision, reduced recovery times, and improved patient outcomes, but high costs have traditionally limited its availability to wealthy nations. By securing regulatory approvals in countries like Kenya and Sri Lanka, SS Innovations is helping to democratize this technology, potentially saving lives and enhancing surgical care in areas with limited medical resources. This expansion could also stimulate local healthcare economies, create training opportunities for medical professionals, and set a precedent for other companies to prioritize affordability in medical innovation, ultimately contributing to more equitable global health standards.
Summary
SS Innovations International, Inc. (Nasdaq: SSII), a developer of innovative surgical robotic technologies, has achieved a significant global expansion milestone with regulatory approval for its SSi Mantra surgical robotic system in four new countries: Colombia, Oman, Sri Lanka, and Kenya. The approvals were granted by INVIMA in Colombia, DGPA&DC in Oman, NMRA in Sri Lanka, and PPB in Kenya, all received between November 2025 and January 2026. This strategic move, announced via PRISM MediaWire, positions the company to address underpenetrated markets by leveraging the SSi Mantra's cost advantages, advanced technology, and user-friendly design, aligning with its mission to democratize access to robotic surgery worldwide.
According to Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, this expansion is part of a broader effort to decentralize excellence in surgical robotic care, with the company also pursuing regulatory pathways in established markets like the United States and European Union. The SSi Mantra, which now has approval in eleven countries including India, Ecuador, and the United Arab Emirates, features modular robotic arms, a 3D 4K monitor, and telesurgery capabilities through the optional SSi MantrAsana Tele Surgeon Console. As of December 2025, the system had an installed base of 168 units across ten countries, performing over 7,885 surgeries, including cardiac and pediatric procedures, and more than 150 telesurgeries.
The company's vision focuses on making robotic surgery affordable and accessible, with the SSi Mantra offering over 40 types of robotic instruments for various specialties. For more information, visit ssinnovations.com or their LinkedIn page. This news underscores SS Innovations' growing influence in the medical technology sector, as it continues to bridge gaps in healthcare access through innovative, cost-effective solutions that could transform surgical outcomes in underserved regions.
Source Statement
This curated news summary relied on content disributed by PRISM Mediawire. Read the original source here, SS Innovations Expands Robotic Surgery Access to Four New Countries
